CDCP1 and type 1 diabetes mellitus: Moreover, CD318 expression in myeloid dendritic cells suppresses the proliferation of autoreactive T cells, a well-known targeted self-antigen in Type 1 Diabetes, demonstrating the involvement of the CD318/CD6 axis in the immunopathogenesis of inflammation [11].